The cost difference between quality and questionable product often matters less than it seems when failed treatment provides zero benefit
The first covers any substance or combination of substances presented as having properties of preventing or treating disease in human beings. The second definition is: Any substance or combination of substances that may be used by, or administered to human beings with a view to restoring, correcting or modifying a physiological function by exerting a pharmacological immunological or metabolic action. While some grey-market peptides may fall under the first definition, David H Reissner, Chair of the Pharmacy Law and Ethics Association, argues that most grey-market peptides should fall within the second broader definition
However, the effects of these injections are real
Be sure to consult directly with providers for exact pricing details
Conversely, normal oxidative-stress biomarkers do not rule out atherosclerosis, high blood pressure, inherited cardiovascular risk, structural heart disease, or other health concerns